Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Politics : Ask Michael Burke -- Ignore unavailable to you. Want to Upgrade?

To: Knighty Tin who wrote (40940)	12/24/1998 11:39:00 PM
From: SOROS	Respond to of 132070

Dear Michael, If anyone needs help, send them my way. Guaranteed to entertain, cure, mold, meld, sniff, warm, tickle, rub, encourage, uhm, what were we talking about? I remain, SOROS techstocks.com

To: Knighty Tin who wrote (40940)	12/25/1998 3:20:00 AM
From: Steve Misic	Read Replies (1) \| Respond to of 132070

Mike, Happy Holidays to you. BTW, CEGE was mentioned in a publication I read as being several years away from approval with the gene-therapy for HIV. Also mentioned for two years out was Trimeris with "fusion inhibitors", Progenics with antibody-like molecule therapy, and VaxGen with a vaccine. Interesting. Steve